Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sernova Corp T.SVA

Alternate Symbol(s):  SEOVF

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.


TSX:SVA - Post by User

Bullboard Posts
Comment by JonEcashon Sep 01, 2017 2:50pm
83 Views
Post# 26648637

RE:Numbnuts Parade

RE:Numbnuts ParadeI agree that there's some negative Nancy's posting dribble here.

A few points:

1. Yes the share price CORRECTED a bit today. What do you expect when a stock goes up for two weeks straight? It went from 15 to 21, so anyone who bought lower than today is able to take some profits. It goes up 40%, and so is allowed to go down 5%. No big deal. And the volume is only 236k shares, which is nothing when this thing can trade in the millions. Myself and others I know hold WAY more than today's volume.

2. You guys are also crying about SVA spending $80,000 on a 12 on more marketing, for only a 12 month commitment? Don't we all want this stock to have as much exposure as possible, especially as the story is getting better? You do remember that we just got USD $2.45m in additional grant money, so this is again peanuts.

3. Also if you read the Q1 FS, our YoY "Salaries, supplies, and contract payments" are LOWER by $88k. So it's not like management is continuing to mindlessly escalate expenses. At least for this first quarter.

4. An announcement of a Big Pharma partnership would be a pop in share price -my guess is much more than where we are now and so if people want to sell at a 50% pop from HERE then they can be my guest. That's what people do, they buy and sell. I don't care if they want to do so early. More power to them.

5. The only thing negative right now is the share price. But if you look at a weekly chart the stock has been under heavy accumulation -even through the recent selling. That means more to me than the daily sp noise.

6. Anything I'm posting is based on publicly released information. I don't have any inside scoop or anything. So unless I see a public release that things are going badly, then I will continue to keep my money invested.

J$

Bullboard Posts